Cargando…
Enhanced Protective Efficacy of a Chimeric Form of the Schistosomiasis Vaccine Antigen Sm-TSP-2
The large extracellular loop of the Schistosoma mansoni tetraspanin, Sm-TSP-2, when fused to a thioredoxin partner and formulated with Freund's adjuvants, has been shown to be an efficacious vaccine against murine schistosomiasis. Moreover, Sm-TSP-2 is uniquely recognised by IgG(1) and IgG(3) f...
Autores principales: | Pearson, Mark S., Pickering, Darren A., McSorley, Henry J., Bethony, Jeffrey M., Tribolet, Leon, Dougall, Annette M., Hotez, Peter J., Loukas, Alex |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Public Library of Science
2012
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3302818/ https://www.ncbi.nlm.nih.gov/pubmed/22428079 http://dx.doi.org/10.1371/journal.pntd.0001564 |
Ejemplares similares
-
DNA Vaccine Encoding the Chimeric Form of Schistosoma mansoni Sm-TSP2 and Sm29 Confers Partial Protection against Challenge Infection
por: Gonçalves de Assis, Natan Raimundo, et al.
Publicado: (2015) -
A randomized, controlled Phase 1b trial of the Sm-TSP-2 Vaccine for intestinal schistosomiasis in healthy Brazilian adults living in an endemic area
por: Diemert, David J., et al.
Publicado: (2023) -
TSP(SM): leading a development team
por: Humphrey, Watts S
Publicado: (2006) -
The Schistosomiasis Research Agenda—What Now?
por: Bethony, Jeffrey M., et al.
Publicado: (2008) -
Vaccination with Schistosoma mansoni Cholinesterases Reduces the Parasite Burden and Egg Viability in a Mouse Model of Schistosomiasis
por: Tedla, Bemnet A., et al.
Publicado: (2020)